Moderna cut to sell from neutral by Rothschild & Co
Rothschild & Co downgraded Moderna to sell from neutral and raised its price target to $81.00 a share from $40.00.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.